β-Cell mass dynamics in Zucker diabetic fatty rats: Rosiglitazone prevents the rise in net cell death

Diabetes

Volumn 50, Issue 5, 2001, Pages 1021-1029

  Finegood, Diane T ^a   McArthur, M Dawn ^a   Kojwang, David ^a   Thomas, Marion J ^a   Topp, Brian G ^a   Leonard, Thomas ^b   Buckingham, Robin E ^b  

^a SIMON FRASER UNIVERSITY   (Canada)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ROSIGLITAZONE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0035042679     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.5.1021     Document Type: Article

References (30)

1. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus
2. Temporal profiles and clinical significance of pulsatile insulin secretion
3. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited
4. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type 2 diabetes: A progressive disease
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
6. Dynamics of beta-cell mass in the growing rat pancreas: Estimation with a simple mathematical model
7. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent: Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells
8. Glucose and tolbutamide induce apoptosis in pancreatic beta-cells: A process dependent on intracellular Ca2+ concentration
9. Neogenesis vs. apoptosis as main components of pancreatic beta cell mass changes in glucose-infused normal and mildly diabetic adult rats
10. Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats
11. Leptin receptor missense mutation in the fatty Zucker rat
12. Rosiglitazone prevents the onset of hyperglycemia and proteinuria in the Zucker diabetic fatty rat
13. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat
14. Thiazolidinediones in the treatment of insulin resistance and type 2 diabetes
15. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone
16. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats
17. Fatty acids, lipotoxicity and insulin secretion
18. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
19. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat
20. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats: Pathogenic implications for obesity-dependent diabetes
21. Contribution of reduced glucose-stimulated b-cell replication in vivo to the pathogenesis of type 2 diabetes in the Zucker diabetic fatty rat
22. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-beta-cell relationships
23. Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in H1T-T 15 cells
24. Patterns of cell death
25. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor
26. Recognition and phagocytosis of cells undergoing apoptosis
27. Increased lipogenic capacity of the islets of obese rats: A role in the pathogenesis of NIDDM
28. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: Role in the pathogenesis of lipotoxic diabetes
29. Thiazolidinedione-induced activation of the transcription factor peroxisome proliferator-activated receptor gamma in cells adjacent to the murine skeletal muscle: Implications for fibroblast functions
30. Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1 beta cytotoxicity